NEW YORK, Feb 27 (Reuters) - Johnson & Johnson on
Monday said the average list price of its drugs rose less than
10 percent each year since 2012, noting that the net price paid
for the drugs, which includes discounts and rebates, was
significantly lower.
Read more
No comments:
Post a Comment